DOCS
Doximity Inc

4,029
Loading...
Loading...
News
all
press releases
Doximity (DOCS) Exceeds Market Returns: Some Facts to Consider
Doximity (DOCS) closed at $73.6 in the latest trading session, marking a +1.28% move from the prior day.
Zacks·5h ago
News Placeholder
More News
News Placeholder
Doximity (DOCS) Increases Despite Market Slip: Here's What You Need to Know
Doximity (DOCS) closed at $71.03 in the latest trading session, marking a +1.1% move from the prior day.
Zacks·6d ago
News Placeholder
HIMS' Personalized Wellness Platform Expands Preventive Care Access
Hims & Hers expands its personalized wellness platform, aiming to reshape preventive care through tech-driven, holistic solutions.
Zacks·16d ago
News Placeholder
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care
HIMS leverages its consumer-first telehealth model, AI-driven personalization and global expansion plans to outpace industry growth.
Zacks·1mo ago
News Placeholder
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
Zacks·1mo ago
News Placeholder
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
Doximity (DOCS) delivered earnings and revenue surprises of +16.13% and +4.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Claritev Corporation (CTEV) Q2 Earnings and Revenues Surpass Estimates
Claritev Corporation (CTEV) delivered earnings and revenue surprises of +111.90% and +4.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Hims & Hers Health, Inc. (HIMS) Misses Q2 Earnings and Revenue Estimates
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -5.56% and -1.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
Zacks·2mo ago
News Placeholder
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
HIMS is transforming digital healthcare with AI-driven care, a booming subscriber base, and new tech leadership.
Zacks·2mo ago

Latest DOCS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.